The acting US FDA commissioner equates drug development in the neurodegenerative diseases to work on HIV.
Janet Woodcock believes that neurodegenerative diseases like Alzheimer’s and amyotrophic lateral sclerosis (ALS) can eventually become chronic conditions if the science continues to develop.
The acting US Food and Drug Administration commissioner, making her first appearance on Capitol Hill in the role, equated drug...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
